Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.97 |
| ▸ | PGR | P06401 | 1/20 | 0.97 |
| ▸ | GAA | P10253 | 1/20 | 0.97 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.97 |
| ▸ | PLK1 | P53350 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | OGG1 | O15527 | 1/20 | 0.46 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbaril SCHEMBL374307 | 0.98 | ALDH1A1 (1.00) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL26737 | 0.98 | ALDH1A1 (1.00) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL29370871 | 0.98 | ALDH1A1 (1.00) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL8855245 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL6054746 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL5197395 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL2521354 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL9515092 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL2426561 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HSD17B10PGRGAAPTGS1 | |
| Carbaril SCHEMBL15874752 | 0.95 | ALDH1A1 (0.88) | ALDH1A1HSD17B10PGRGAAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2008506881-A | — | — | 2008-03-06 | — | — | JP | claimed |
| EP-1784247-A1 | HYBRID CATALYST SYSTEM FOR EXHAUST EMISSIONS REDUCTION | EATON CORPORATION (US) | 2007-05-16 | — | — | EP | claimed |
| WO-2006008625-A1 | HYBRID CATALYST SYSTEM FOR EXHAUST EMISSIONS REDUCTION | EATON CORPORATION (DE) | 2006-01-26 | — | — | WO | claimed |
| US-5244539-A | Nitric acid, source of ferric ions, halide ions, ammonium ions | ARDROX, INC. (US) | 1993-09-14 | — | — | US | claimed |
| EP-3894402-B1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN LA ROCHE (CH) | 2023-07-05 | — | — | EP | disclosed |
| US-20220169639-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2022-06-02 | — | — | US | disclosed |
| EP-3894402-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. Hoffmann-La Roche AG (CH) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020120528-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-18 | — | — | WO | disclosed |
| US-20180257028-A1 | PROCESS AND APPARATUS FOR 5 CAPTURING GASEOUS AMMONIA | ANDREWS DIRK (US) | 2018-09-13 | — | — | US | disclosed |
| US-9993770-B2 | Process and apparatus for capturing gaseous ammonia | ANDREWS DIRK (US) | 2018-06-12 | — | — | US | disclosed |
| US-9993770-B2 | Process and apparatus for capturing gaseous ammonia | ANDREWS DIRK (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170128880-A1 | PROCESS AND APPARATUS FOR CAPTURING GASEOUS AMMONIA | ANDREWS DIRK (US) | 2017-05-11 | — | — | US | disclosed |
| US-20060010857-A1 | Hybrid catalyst system for exhaust emissions reduction | EATON CORPORATION (US) | 2006-01-19 | — | — | US | disclosed |
| WO-2006000877-A2 | STRATEGY FOR CONTROLLING NOX EMISSIONS AND AMMONIA SLIP IN AN SCR SYSTEM USING A NONSELECTIVE NOX/NH3 SENSOR | EATON CORPORATION (US) | 2006-01-05 | — | — | WO | disclosed |
| US-20050284134-A1 | MULTISTAGE REDUCTANT INJECTION STRATEGY FOR SLIPLESS, HIGH EFFICIENCY SELECTIVE CATALYTIC REDUCTION | EATON CORPORATION (US) | 2005-12-29 | — | — | US | disclosed |
| US-20050282285-A1 | Strategy for controlling NOx emissions and ammonia slip in an SCR system using a nonselective NOx/NH3 | EATON CORPORATION (US) | 2005-12-22 | — | — | US | disclosed |
| WO-2005106219-A1 | TEMPERATURE SWING ADSORPTION AND SELECTIVE CATALYTIC REDUCTION NOX REMOVAL SYSTEM | EATON CORPORATION (US) | 2005-11-10 | — | — | WO | disclosed |
| US-20050247049-A1 | Temperature swing adsorption and selective catalytic reduction NOx removal system | EATON CORPORATION (US) | 2005-11-10 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| US-5244539-A | Nitric acid, source of ferric ions, halide ions, ammonium ions | ARDROX, INC. (US) | 1993-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169639-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HAVCR2, NR0B1, CYP7A1 | ALDH1A1 889/4885HSD17B10 918/4885PGR 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.